Healthcare resource utilization among patients with relapsed multiple myeloma in the UK, France, and Italy.

about

Healthcare resource utilization among patients with relapsed multiple myeloma in the UK, France, and Italy.

Item

http://www.wikidata.org/entity/Q47248893

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Healthcare resource utilizatio ...... in the UK, France, and Italy.

@en

Healthcare resource utilizatio ...... in the UK, France, and Italy.

@nl

type

Item

label

Healthcare resource utilizatio ...... in the UK, France, and Italy.

@en

Healthcare resource utilizatio ...... in the UK, France, and Italy.

@nl

prefLabel

Healthcare resource utilizatio ...... in the UK, France, and Italy.

@en

Healthcare resource utilizatio ...... in the UK, France, and Italy.

@nl

P1476

Healthcare resource utilizatio ...... in the UK, France, and Italy.

@en

P2093

Alain Flinois

http://www.w3.org/2001/XMLSchema#string

Carlotta Gazzola

http://www.w3.org/2001/XMLSchema#string

Francesco S Mennini

http://www.w3.org/2001/XMLSchema#string

Henri Leleu

http://www.w3.org/2001/XMLSchema#string

Kwee Yong

http://www.w3.org/2001/XMLSchema#string

Leah Fink

http://www.w3.org/2001/XMLSchema#string

Lucy DeCosta

http://www.w3.org/2001/XMLSchema#string

Marco Campioni

http://www.w3.org/2001/XMLSchema#string

Paul Schoen

http://www.w3.org/2001/XMLSchema#string

Sebastian Gonzalez-McQuire

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical characteristics of patients with relapsed multiple myeloma

European perspective on multiple myeloma treatment strategies in 2014

The role of maintenance therapy in multiple myeloma

Double Relapsed and/or Refractory Multiple Myeloma: Clinical Outcomes and Real World Healthcare Costs

Analysis of the cost-effectiveness of surfactant treatment (Curosurf®) in respiratory distress syndrome therapy in preterm infants: early treatment compared to late treatment

Hospital costs of central line-associated bloodstream infections and cost-effectiveness of closed vs. open infusion containers. The case of Intensive Care Units in Italy.

International uniform response criteria for multiple myeloma.

Improved survival in multiple myeloma and the impact of novel therapies.

Economic evaluation of therapies for patients suffering from relapsed-refractory multiple myeloma in Greece.

Multiple myeloma: causes and consequences of delay in diagnosis.

P304

1-18

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/13696998.2017.1421546

http://www.w3.org/2001/XMLSchema#string

P407

English

P577

2017-12-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29278014

http://www.w3.org/2001/XMLSchema#string

P921

An Eadailt